82C Stock Overview
Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
NIOX Group Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.70 |
| 52 Week High | UK£0.88 |
| 52 Week Low | UK£0.58 |
| Beta | 0.45 |
| 1 Month Change | -2.78% |
| 3 Month Change | 1.45% |
| 1 Year Change | -13.04% |
| 3 Year Change | 70.73% |
| 5 Year Change | 187.47% |
| Change since IPO | -80.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 82C | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 9.4% | -1.5% | 2.4% |
| 1Y | -13.0% | -12.9% | 13.2% |
Return vs Industry: 82C matched the German Medical Equipment industry which returned -12.3% over the past year.
Return vs Market: 82C underperformed the German Market which returned 12.8% over the past year.
Price Volatility
| 82C volatility | |
|---|---|
| 82C Average Weekly Movement | 11.2% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 82C's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 82C's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 91 | Jonathan Emms | www.niox.com |
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.
NIOX Group Plc Fundamentals Summary
| 82C fundamental statistics | |
|---|---|
| Market cap | €308.29m |
| Earnings (TTM) | €4.01m |
| Revenue (TTM) | €49.32m |
76.9x
P/E Ratio6.3x
P/S RatioIs 82C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 82C income statement (TTM) | |
|---|---|
| Revenue | UK£41.80m |
| Cost of Revenue | UK£11.60m |
| Gross Profit | UK£30.20m |
| Other Expenses | UK£26.80m |
| Earnings | UK£3.40m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0085 |
| Gross Margin | 72.25% |
| Net Profit Margin | 8.13% |
| Debt/Equity Ratio | 0% |
How did 82C perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield154%
Payout RatioDoes 82C pay a reliable dividends?
See 82C dividend history and benchmarks| NIOX Group dividend dates | |
|---|---|
| Ex Dividend Date | May 15 2025 |
| Dividend Pay Date | Jun 16 2025 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 37 days |
Does 82C pay a reliable dividends?
See 82C dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/08 20:36 |
| End of Day Share Price | 2025/05/08 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NIOX Group Plc is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Julie Simmonds | Canaccord Genuity |
| Jens Lindqvist | Investec Bank plc (UK) |
| Richard Vosser | J.P. Morgan |